Document is current
Any future updates will be listed below
-
Authors
Gandhi, Sirin
Marr, Karen
Mancini, Marcello
Caprio, Maria Grazia
Jakimovski, Dejan
Chandra, Avinash
Hagemeier, Jesper
Hojnacki, David
Kolb, Channa
Weinstock-Guttman, Bianca
Zivadinov, Robert http://orcid.org/0000-0002-7799-1485
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR001412)
The Annette Funicello Research Fund for Neurological Diseases (N/A)
Jacquemin Family Foundation (N/A)
- License Information
-
More Information
Article History
Received: 1 October 2018
Accepted: 31 May 2019
First Online: 11 June 2019
Ethics approval and consent to participate
: The study was approved by the local Institutional Review Board of the University of Buffalo, USA and University of Naples, Italy and written informed consent was obtained by all study participants prior to enrollment. The IRB renewals were obtained annually on an ongoing basis throughout the study.
: Not applicable.
: Sirin Gandhi, Karen Marr, Maria Grazia Caprio, Dejan Jakimovski, Avinash Chandra and Jesper Hagemeier have nothing to disclose.Marcello Mancini received personal compensation from SDN S.p.A.David Hojnacki has received speaker honoraria and consultant fees from Biogen Idec, Teva Pharmaceutical Industries Ltd., EMD Serono, Pfizer Inc., and Novartis.Channa Kolb has received speaker honoraria from Novartis, Genzyme and Biogen-Idec.Bianca Weinstock- Guttman received honoraria as a speaker and as a consultant for Biogen Idec, Teva Pharmaceuticals, EMD Serono, Genzyme&Sanofi, Novartis and Acorda. Dr. Weinstock-Guttman received research funds from Biogen Idec, Teva Pharmaceuticals, EMD Serono, Genzyme&Sanofi, Novartis, Acorda.Robert Zivadinov received personal compensation from EMD Serono, Genzyme-Sanofi, Claret Medical, Celgene and Novartis for speaking and consultant fees. He received financial support for research activities from Roche-Genenetech, Teva Pharmaceuticals, Genzyme-Sanofi, Novartis, Claret Medical, Intekrin-Coherus and IMS Health.
